Mumbai-based Brilliance Cosmocare has raised $200,000 in seed funding. The company wants to build a doctor-led skin health platform focused on longevity and preventive care.
Aesthetic surgeon Dr Ashok Patel founded Brilliance Cosmocare after years of clinical practice. The company says it has treated more than 12,000 patients over the past decade.
Moving beyond one-time cosmetic treatments
The startup aims to shift anti-ageing care away from one-time cosmetic procedures. Instead, it focuses on early diagnosis, treatment plans and long-term monitoring. The company raised about Rs 1.65 crore from family offices and institutional investors. It will use the funding to strengthen clinical infrastructure and develop preventive-care products.
The funding will also support the expansion of its Skin Record data platform. The platform aims to track changes in patients’ skin health over time.
Using technology for personalised skin care
Brilliance Cosmocare uses an AI-assisted diagnostic scan during its patient assessment process. The scan evaluates several indicators linked to overall skin health. These indicators include skin age, hydration, pigmentation, UV damage and skin barrier health. Doctors then use the results to create individual treatment plans.
The company says this diagnosis-first model can reduce reliance on trend-driven skincare recommendations. It also aims to connect treatments with measurable clinical outcomes. Brilliance Cosmocare operates a clinic in Mumbai’s Andheri West. It also offers a doctor-formulated skincare product line alongside its clinical services.
The company is developing an AI-powered longitudinal skin record platform. It also plans to develop a preventive nutraceutical portfolio.
Building a long-term approach to ageing
Dr Patel said the company views anti-ageing as a long-term approach to skin health. He said early diagnosis should guide decisions instead of visible signs of ageing.
Co-founder and Director Satyapal Chandra said ageing well will become an important healthcare conversation in India. He said the company wants to build long-term trust with patients.
Brilliance Cosmocare describes its focus as skin and hair longevity rather than conventional dermatology. Its approach combines clinical assessment, technology and ongoing monitoring.
Targeting India’s growing skin health market
The company enters a rapidly growing Indian skincare and aesthetic medicine market. Industry estimates place the market at nearly US$5 billion currently. The market could exceed US$11 billion by 2032, according to industry estimates cited in the announcement. It could also grow at nearly 15 per cent annually.
Brilliance Cosmocare believes growing demand creates opportunities for evidence-based skin health companies. Its strategy centres on diagnosis, data and personalised care. The company also points to growing investor interest in scientific skincare brands. Hindustan Unilever’s acquisition of Minimalist reflects this broader market trend.
Expanding clinical and preventive-care capabilities
With its new funding, Brilliance Cosmocare plans to expand its clinical and technology infrastructure. It also intends to strengthen its preventive-care product pipeline. The company ultimately wants to build a long-term skin health platform for Indian consumers. Its model combines medical expertise, artificial intelligence and longitudinal health data.
Brilliance Cosmocare says its goal extends beyond cosmetic improvements. It wants to help patients monitor and manage skin health throughout their lives.
Also read: